These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3922319)

  • 21. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
    Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
    J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
    Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent activation of 2-acetylaminofluorene and some aromatic amines by cytosolic preparations.
    Forster R; Green MH; Priestley A; Gorrod JW
    Mutat Res; 1981 Aug; 85(4):187-94. PubMed ID: 7022188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dose on the inhibition of carcinogenesis/mutagenesis by Aroclor 1254 in rainbow trout fed aflatoxin B1.
    Shelton DW; Hendricks JD; Coulombe RA; Bailey GS
    J Toxicol Environ Health; 1984; 13(4-6):649-57. PubMed ID: 6436502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between vitamin A dietary intake and mutagenic activity of some chemical carcinogens.
    Cassand P; Leveque F; Decoudu S; Narbonne JF
    Food Addit Contam; 1990; 7 Suppl 1():S58-9. PubMed ID: 2124552
    [No Abstract]   [Full Text] [Related]  

  • 27. Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin, a natural anthraquinone.
    Bösch R; Friederich U; Lutz WK; Brocker E; Bachmann M; Schlatter C
    Mutat Res; 1987 Jul; 188(3):161-8. PubMed ID: 3110611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sovol as an inducer of procarcinogen activating microsomal enzymes].
    Belitskiĭ GA; Fonshteĭn LM; Khudoleĭ VV; Demakov VA; Kiseleva MG
    Eksp Onkol; 1987; 9(3):20-3. PubMed ID: 3111822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo binding of 3,3'-dichlorobenzidine to rat and mouse tissue DNA.
    Ghosal A; Iba MM
    Cancer Lett; 1990 Sep; 53(2-3):197-204. PubMed ID: 2208080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of S9 activation by S105 cytosolic fraction.
    Forster R; Green MH; Priestley A
    Carcinogenesis; 1981; 2(11):1081-5. PubMed ID: 7032740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation with isolated hepatocytes from rats and hamsters.
    Ho LL; Jhee EC; Gopalan P; Tsuji K; Lotlikar PD
    IARC Sci Publ; 1991; (105):427-30. PubMed ID: 1906837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring the exposure of rats to 2-acetylaminofluorene by the estimation of mutagenic activity in excreta, sister-chromatid exchanges in peripheral blood cells and DNA adducts in peripheral blood, liver and spleen.
    Willems MI; de Raat WK; Baan RA; Wilmer JW; Lansbergen MJ; Lohman PH
    Mutat Res; 1987 Feb; 176(2):211-23. PubMed ID: 3543665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activation of aflatoxin B1 in liver slices and in bacterial mutagenicity assays using livers from different species including man.
    Booth SC; Bösenberg H; Garner RC; Hertzog PJ; Norpoth K
    Carcinogenesis; 1981; 2(10):1063-8. PubMed ID: 6794925
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of 3,3'-dichlorobenzidine in rat liver microsomes to mutagens: involvement of cytochrome P-450d.
    Iba MM; Thomas PE
    Carcinogenesis; 1988 May; 9(5):717-23. PubMed ID: 3130202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aflatoxin B1 metabolism in the rat: polyhalogenated biphenyl enhanced conversion to aflatoxin M1.
    Shepherd EC; Phillips TD; Irvin TR; Safe SH; Robertson LW
    Xenobiotica; 1984 Sep; 14(9):741-50. PubMed ID: 6097059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroperoxidase I catalyzes peroxidative activation of 3,3'-dichlorobenzidine to a mutagen in Salmonella typhimurium.
    McGowan-Jordan IJ; Josephy PD
    Arch Biochem Biophys; 1990 Nov; 282(2):352-7. PubMed ID: 2241156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent interaction of 3,3'-dichlorobenzidine with hepatic lipids. Enzymic basis and stability of the adducts.
    Iba MM; Lang B; Thomas PE; Ghosal A
    Biochem Pharmacol; 1990 Aug; 40(3):581-7. PubMed ID: 2116801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.